Patents Assigned to SINOPIA BIOSCIENCES, INC.
  • Isotopically-labelled trapidil derivatives
    Patent number: 12508267
    Abstract: Provided are isotopically-labelled Trapidil derivatives useful for the treatment of Parkinson's disease and movement disorders associated with Parkinson's disease. The isotopically-labelled Trapidil derivatives include deuterated Trapidil derivatives. Additionally provided are combination therapies of isotopically-labelled Trapidil derivatives and additional therapeutic agents for the treatment of Parkinson's disease and movement disorders associated with Parkinson's disease.
    Type: Grant
    Filed: September 23, 2022
    Date of Patent: December 30, 2025
    Assignee: SINOPIA BIOSCIENCES, INC.
    Inventors: Aarash Bordbar, Warren S. Wade, Hiroko Masamune
  • Treating extrapyramidal syndrome using trapidil
    Patent number: 12268691
    Abstract: Disclosed herein are methods, pharmaceutical combinations, or kits for the prevention or treatment of extrapyramidal syndromes, for example, dyskinesia, dystonia, akathisia, or drug-induced Parkinsonism, with the administration of a therapeutic effective amount of Trapidil, a derivative, a metabolite, a prodrug, an analog, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 1, 2023
    Date of Patent: April 8, 2025
    Assignee: SINOPIA BIOSCIENCES, INC.
    Inventor: Aarash Bordbar
  • Treating extrapyramtdal syndrome using trapidil
    Patent number: 11628170
    Abstract: Disclosed herein are methods, pharmaceutical combinations, or kits for the prevention or treatment of extrapyramidal syndromes, for example, dyskinesia, dystonia, akathisia, or drug-induced Parkinsonism, with the administration of a therapeutic effective amount of Trapidil, a derivative, a metabolite, a prodrug, an analog, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: April 18, 2023
    Assignee: SINOPIA BIOSCIENCES, INC.
    Inventor: Aarash Bordbar
  • Treating extrapyramidal syndrome using trapidil
    Patent number: 10350212
    Abstract: Disclosed herein are methods, pharmaceutical combinations, or kits for the prevention or treatment of extrapyramidal syndromes, for example, dyskinesia, dystonia, akathisia, or drug-induced Parkinsonism, with the administration of a therapeutic effective amount of Trapidil, a derivative, a metabolite, a prodrug, an analog, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: July 16, 2019
    Assignee: SINOPIA BIOSCIENCES, INC.
    Inventor: Aarash Bordbar